Skip to main content
. 2021 Jun 30;2021(6):CD003748. doi: 10.1002/14651858.CD003748.pub5

Comparison 2. Cilostazol 100 mg twice daily versus pentoxifylline 400 mg three times daily.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
2.1 Initial claudication distance (ICD) 1 417 Mean Difference (IV, Fixed, 95% CI) 20.00 [‐2.57, 42.57]
2.2 Absolute claudication distance (ACD) 2 866 Mean Difference (IV, Random, 95% CI) 13.43 [‐43.50, 70.36]
2.3 Adverse event related to study medication ‐ headache 2 982 Odds Ratio (M‐H, Random, 95% CI) 2.20 [1.16, 4.17]
2.4 Adverse event related to study medication ‐ diarrhoea 2 982 Odds Ratio (M‐H, Random, 95% CI) 1.80 [0.79, 4.12]
2.5 Adverse event related to study medication ‐ abnormal stools 1 459 Odds Ratio (M‐H, Fixed, 95% CI) 3.12 [1.57, 6.21]
2.6 Adverse event related to study medication ‐ pain 2 982 Odds Ratio (M‐H, Fixed, 95% CI) 0.85 [0.57, 1.26]
2.7 Adverse event related to study medication ‐ palpitations 2 982 Odds Ratio (M‐H, Fixed, 95% CI) 8.35 [4.11, 16.98]
2.8 All‐cause mortality 3 1229 Odds Ratio (M‐H, Fixed, 95% CI) 0.58 [0.17, 1.98]
2.9 Ankle brachial index (ABI) 1 417 Mean Difference (IV, Fixed, 95% CI) ‐0.01 [‐0.12, 0.10]